Effect of comprehensive treatment of Mammary meridian on breast distending pain and promoting breastfeeding in primipara after Cesarean section

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100046434

Enrollment

Unknown

Registered

2021-05-15

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Puerperal breast distending pain

Interventions

experimental group:Comprehensive treatment of mammary meridian

Control Group:Routine nursing after Cesarean section

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20 to 45 years; 2. Full-term delivery, single birth, primipara; 3. Perform cesarean section; 4. Meet the diagnostic criteria for postpartum breast swelling; 5. Informed consent to this study.

Exclusion criteria

Exclusion criteria: 1. Parturients with blood system disorders; 2. Patients who are infected with human immunodeficiency virus (HIV) or Treponema pallidum; 3. Heart and lung diseases; infectious diseases such as hepatitis and tuberculosis; 4. Serious breast disease caused serious damage to breast tissue; 5. Breast herpes simplex virus infection; 6. Maternal cognitive impairment; 7. Refuse to breastfeed or give up neonatal treatment in a critically ill neonate.

Design outcomes

Primary

Measure	Time frame
numerical rating scale;breast swelling hardness;	—

Secondary

Measure	Time frame
the breastfeeding self-efficacy scale;the rate of pure breast feeding;	—

Countries

China

Contacts

Public ContactHuang Shan

Tianjin First Central Hospital

ivy13512001143@163.com+86 13512001143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026